Status:
COMPLETED
Efficacy of Fish Oil in Multiple Sclerosis
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Conditions:
Relapsing- Remitting Multiple Sclerosis
Eligibility:
All Genders
18-55 years
Phase:
PHASE4
Brief Summary
The aim of the present work was to evaluate the efficacy of fish oil supplementation on serum proinflammatory cytokines levels, oxidative stress markers and disease progression in MS.
Detailed Description
Current research findings suggest that Omega-3 polyunsaturated fatty acids (PUFA) such as eicosahexanoic acid (EPA) and docosahexaenoic acid (DHA) contained in fish oil may have anti-inflammatory, ant...
Eligibility Criteria
Inclusion
- Patients had clinically definite and magnetic resonance image supported MS
- Had at least one relapse in the year before entry into the study
- EDSS score of 0-5
- Treated with subcutaneous 250 μg interferon beta-1b (Betaseron, Bayer)
Exclusion
- they were taking another supplement
- had progressive forms of MS
- had history of severe depression
- had history of acute liver or renal dysfunction
- had history of tobacco, drug or alcohol abuse
- had intolerance, contraindication or allergy to fish oil
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01842191
Start Date
May 1 2010
End Date
December 1 2012
Last Update
May 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IMSS, Specialties Hospital, Neurology Departament
Guadalajara, Jalisco, Mexico, 44340